Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Debt / NOTE 4.000% 5/0
-
Market price (% of par)
-
152.25%
-
Total 13F principal
-
$296,243,895
-
Principal change
-
-$3,294,050
-
Total reported market value
-
$450,609,974
-
Number of holders
-
35
-
Value change
-
-$6,401,282
-
Number of buys
-
8
-
Number of sells
-
15
Institutional Holders of MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 as of Q4 2024
As of 31 Dec 2024,
MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 was held by
35 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$296,243,895
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., AMERIPRISE FINANCIAL INC, FMR LLC, BNP PARIBAS FINANCIAL MARKETS, and SSI INVESTMENT MANAGEMENT LLC.
This page lists
35
institutional bondholders reporting positions
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.